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SummAry
The present study examined the clinico-pathological profile of sinonasal masses in patients attending an Ear nose Throat clinic of a rural 
tertiary care hospital of western maharashtra in india, between may 2007 to June 2009. During the study period, 112 patients presented 
with sinonasal masses (male 68, female 44; age group 8-70 years). nasal polyploid masses were non-neoplastic in 80 (71.4%) subjects, and 
neoplastic in 32 (28.6%) cases. nasal obstruction was the most common (97.3%) presenting complaint, followed by rhinorrhoea (49.1%), 
hyposmia (31.25%), intermittent epistaxis (17.9%), headache (16.9%), facial swelling (11.6%) and eye-related symptoms (10.7%). The 
most common site of origin of polyploid masses was the middle meatus (54.4%) followed by the lateral wall of the nasal cavity (16.1%) and 
superior meatus (10.7%). unilateral nasal masses was present in 47.7% patients, while the remaining patients had bilateral nasal masses. 
Allergic (62.5%) and inflammatory (25%) polyps were the most common non-neoplastic mass. haemangioma (47.3%) and inverted papil-
loma (36.8%) were most common benign neoplastic mass; 92.3% of all malignant masses were squamous cell carcinoma. Surgery was 
the major mode of treatment. it included Caldwell-luc operation (7.1%), polypectomy (17.8%), excision of mass (25.0%) and functional 
endoscopic sinus surgery (44.6%). malignancies were treated with radiotherapy.
KEy worDS: Sino nasal mass • Polyp • Nasal obstruction • Squamous cell carcinoma • FESS
riASSunTo
In questo studio vengono presi in esame gli aspetti clinico-patologici delle masse nasosinusali in pazienti seguiti presso la Clinica Otorino-
laringoiatrica del centro di cura ospedaliero di Maharashtra in India, nel periodo compreso tra il maggio 2007 ed il giugno 2009. Durante 
il periodo di studio una massa nasosinusale è stata riscontrata in 112 pazienti (68 maschi, 44 femmine; range di età 8-70 anni). Masse 
naso sinusali di tipo non neoplastico sono state riscontrate in 80 pazienti (71,4%) mentre quelle di tipo neoplastico in 32 pazienti (28,6%). 
L’ostruzione nasale è stato il sintomo più comunemente riferito (97,32%), seguito da rinorrea (49,1%), iposmia (31,25%), epistassi in-
termittente (17,85%), cefalea (16,87%), tumefazione del volto (11,6%) e sintomi oculari (10,71%). La sede di origine più comune delle 
masse di tipo polipoide è stato il meato medio (54,46%), seguito dalla parete laterale della cavità nasale (16.07%) e dal meato superiore 
(10,7%). Nel 47,74% dei pazienti sono state osservate masse naso sinusali unilaterali, mentre nei restanti casi le lesioni erano bilaterali. 
I polipi su base allergica (62,5%) ed infiammatoria (25%) rappresentavano le masse di tipo non neoplastico più comunemente osservate. 
Gli emangiomi (47,3%) e i papillomi invertiti (36,8%) rappresentavano le masse neoplastiche benigne osservate più di frequente. Il carci-
noma a cellule squamose ha rappresentato il 92,3% di tutte le masse neoplastiche maligne. La chirurgia è stata la scelta principale per il 
trattamento dei pazienti, ed in particolare l’intervento di Caldwell-Luc (7,1%), la polipectomia (17,8%), l’escissione della massa (25%) e 
la chirurgia endoscopica sinusale funzionale (44,6%). Le neoplasie maligne sono state trattate con radioterapia.
ParolE chiavE: Massa nasosinusale • Polipo • Ostruzione nasale • Carcinoma a cellule squamose • FESS
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Introduction
The nose is the most prominent part of the face with sub-
stantial aesthetic and functional significance. it is one of 
the few organs of body invested with an aura of emotional 
and cultural importance. Anatomical location of the nose 
and it passage have been regarded as the direct avenue to 
the brain, man’s source of intelligence and spirituality.
nasal masses are common finding in an EnT (Ear, nose 
and Throat) outpatient department. most patients present 
with complaints of nasal obstruction 1. other symptoms 
include  nasal  discharge,  epistaxis  and  disturbances  of 
smell. A sinonasal mass can have various differential diag-
noses. They may be congenital, inflammatory, neoplastic 
(benign or malignant) or traumatic in nature. A congenital 
nasal mass may present intranasally, extranasally, or as 
external nasal mass with or without nasal obstruction 2. 
Congenital masses are predominantly mid line swellings 
and include dermoids, glioma and encephaloceles as com-
mon diagnoses 3. Polyps are a common cause of nasal ob-Clinico-pathological profile of sinonasal masses
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Results
During the study period, 112 patients presented with si-
nonasal masses, and confirmed by various investigations. 
The socio-demographic details of the study population 
are given in Table i.
nasal  polyploidal  masses  were  non-neoplastic  in  80 
(71.4%) study subjects, and neoplastic in 32 (28.6%) pa-
tients (Table ii). The age range of the patients were 8 to 70 
years. non-neoplastic polypoid masses were common in 
the age group 11 to 40 years. Benign neoplastic polypoid 
struction in adults with a prevalence of about 4% in the 
general population 4.
Polyp is a general term used to describe any mass of tis-
sue that bulges or projects downwards from the normal 
surface and is macroscopically visible. it is also known as 
prolapsed pedunculated mucosa. This condition is well-
known with little improvement in its treatment modality, 
although it is a common condition; the exact aetiopatho-
logical correlation is still unknown. hippocrates gave a 
graphic description of nasal polypoidal masses as early as 
460-370 B.c., and can thus be considered the “Father of 
rhinology”. Forestus (1522-1597 a.D.) described a case 
of a woman whose nasal polyps, according to him, were 
due to forcing of mucous membrane into the nose, which 
he attributed to her carrying heavy weights on her head.
The trend and tradition of a clinical entity changes with 
time. Tandon et al. 5 and Dasgupta et al. 6 devoted consid-
erable effort in the study of sinonasal masses in the indian 
population. however, to date an analysis of the sinonasal 
masses in the rural population of india has been lacking. 
The  present  investigation  was  undertaken  to  study  the 
clinico-pathological profile of sinonasal masses in a rural 
tertiary care hospital of western maharashtra, india.
Materials and methods
The study was carried out at rural medical College and 
Pravara  rural  hospital,  loni,  which  is  a  tertiary  care 
hospital in western maharashtra, india. The EnT depart-
ment of the hospital predominantly receives patients from 
Ahmednagar and nashik districts. All patients diagnosed 
with sinonasal masses during the period from may 2007 
to June 2009 were included. The criteria for selection of 
cases were mainly based on history and clinical examina-
tion. Detailed history was taken considering the patients’ 
complaints, mainly nasal obstruction, mass in the nose, 
epistaxis, rhinorrhoea, hyposmia and deformity of nose 
and face. occupational history, personal habits and so-
cioeconomic status of patients were documented. Socio-
economic status was assessed according to the modified 
BG Prasad classification based on consumer Price index 
of April 2006 7 8. Clinical examinations were carried out as 
per standard protocols. Appropriate radiological and lab-
oratory investigations were done as appropriate. Biopsy 
was taken from all cases for histopathological examina-
tion to confirm diagnosis. Earlier workers used different 
terms for the same pathological entity and the same term 
for lesions of different types. world health organization 
classification (1978, 1991) 9 10 was adopted to describe the 
lesion. Patients were treated either by pharmacotherapy, 
surgery, radiotherapy or chemotherapy or a combination 
as appropriate. Patients were asked for regular follow up. 
Ethical approval was obtained from the institutional Ethi-
cal Committee of the medical college. Data was analysed 
using microsoft office Excel 2007.
Table I. Socio-demographic characteristics of study population.
N (%)
Gender
  Male  68 (60.7)
  Female 44 (39.2)
  Total 112 (100)
Age Group
  < 10 years 11 (9.8)
  11-20 years 24 (21.4)
  21-30 years 22 (19.6)
  31-40 years 23 (20.5)
  41-50 years 15 (13.4)
  51-60 years 6 (5.4)
  61-70 years 11 (9.8)
Mean Age (in years), (SD) 31.2 (7.4)
Education
  Graduate and above 8 (7.1)
  Intermediate/Matriculation 12 (10.7)
  Secondary 20 (17.8)
  Primary  32 (28.6)
  Illiterate 40 (35.7)
Occupation
  Farmer 45 (40.2)
  Labourer 37 (33)
  Business 3 (2.7)
  Service 5 (4.5)
  Student 17 (15.1)
  Others 5 (4.5)
Socioeconomic Status
  Upper 0 (0)
  Upper middle 0 (0)
  Middle 8 (7.1) 
  Lower middle 67 (59.8)
  Lower 37 (33)
Dietary Habit
  Vegetarian 45 (40.2)
  Non-vegetarian 67 (59.8)
Religion
  Hindu 63 (56.2)
  Muslim 35 (31.3)
  Christian 7 (6.2)
  Others 7 (6.2)A. lathi et al.
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masses were common in the age range of 11 to 50 years, 
while malignant neoplastic polypoid masses were more 
common after the third decade of life (Table iii).
nasal obstruction was the most common (97.3% cases) 
presenting  complaint.  rhinorrhoea  (49.1%),  hypos-
mia  (31.3%),  intermittent  epistaxis  (17.9%),  headache 
(16.9%),  swelling  over  face  (11.6%)  and  eye  related 
symptoms (10.7%) were other common symptoms. Fa-
cial  pain  (3.9%)  and  external  nasal  deformity  (1.8%) 
were demonstrated in a minority of patients. unilateral 
nasal masses were observed in 47.7% patients, while the 
remaining patients had bilateral nasal masses. All the be-
nign as well as malignant polypoid masses presented uni-
laterally, with the exception one benign neoplastic mass. 
Among  non-neoplastic  polypoid  nasal  masses,  69.4% 
were multiple and 30.6% presented as a single mass. All 
benign and malignant nasal polypoid masses were found 
to be single except in one malignant case (Table iv). The 
most common site of origin of the polyploid masses was 
the middle meatus (54.5%) followed by the lateral wall 
of the nasal cavity (16.1%) and superior meatus (10.7%). 
The study further revealed that of 70 cases of true nasal 
polyps, 60 (85.1%) originated from the middle meatus 
and 10 (14.3%) from the superior meatus. mucoid dis-
charge was found to be common in non-neoplastic nasal 
polypoid masses. All patients with malignant neoplastic 
polypoid masses presented with blood stained discharge 
or intermittent epistaxis (Table v).
histopathological  examination  revealed  that  44.6% 
(n = 50) of the polyps to be allergic in nature (ethmoi-
dal polyp), while 17.8% (n = 20) were inflammatory (an-
trochoanal polyp). rhinoscleroma and rhinosporodiosis 
were the other two non neoplastic lesions confirmed by 
histopathological  investigation  (Table  vi). all  patients 
with rhinoscleroma were in the third decade of life with 
a male-female ratio of 3:1 (6 males, 2 females). Among 
benign  neoplastic  lesions,  haemangioma  was  the  most 
common (n = 9) followed by inverted papilloma (n = 7). 
mucocele and angiofibroma were only seen in 2 and 1 
cases, respectively. Squamous cell carcinoma represent-
ed 92.3% all sinonasal malignancies (Table vi). Surgery 
was the major mode of treatment in all cases. it included 
Caldwell-luc  operation  (7.1%),  polypectomy  (17.8%), 
Table II. Incidence of nasal masses and grouped according to gender.
Type of mass Male Female Total
Non-neoplastic 46 34 80
Neoplastic
  Benign 12 07 19
  Malignant 10 3 13
Total 68 44 112
Table III. Distribution of nasal masses according to age.
Age
(years)
Non-neoplastic 
mass
Neoplastic mass Total
Benign Malignant
< 10  11 0 0 11
11-20 21 3 0 24
21-30 19 3 0 22
31-40 19 4 0 23
41-50 5 7 3 15
51-60 2 1 3 6
61-70 3 1 7 11
Total 80 19 13 112
Table IV. Presentation of nasal masses in the nasal cavity.
Non-neoplastic 
mass
Neoplastic mass Total
Benign Malignant
Laterality
  Unilateral 23 18 13 54
  Bilateral 57 1 0 58
  Total 80 19 13 112
Number
  Single 22 18 12 52
  Multiple 50 0 1 51
  Total 72* 18** 13 103
* Cases of rhinoscleroma are not considered; ** a case of angiofibroma is not 
considered.
Table V. Type of nasal discharge through nose.
Non-neoplastic mass Neoplastic mass
Benign Malignant
Mucoid 27 02 -
Mucopurulent 15 01 -
Foul smelling 02 - -
Blood-stained/
   intermittent
   epistaxis
03 01 13
Table VI. Histopathological findings of nasal polypoid masses.
N (%)
Non neoplastic mass
  Allergic polyp 50 (62.5)
  Inflammatory polyp 20 (25)
  Rhinoscleroma 8 (10)
  Rhinosporodiosis 2 (2.5)
  Total 80 (100)
Benign neoplastic mass
  Haemangioma 9 (47.3)
  Inverted papilloma 7 (36.8)
  Mucocele 2 (10.5)
  Angiofibroma 1 (5.3)
  Total 19 (100)
Malignant neoplastic mass 
  Squamous cell
  carcinoma
12 (92.3)
  Adenocarcinoma 1 (7.6)
  Total 13 (100)Clinico-pathological profile of sinonasal masses
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excision of mass (25.0%) and functional endoscopic sinus 
surgery (FESS) (44.6%). chemotherapy and/or radiother-
apy were considered as the treatment of choice in 17.8% 
of patients. Among 20 cases of antrochoanal polyp, 12 
(60%) patients were treated with polypectomy by avul-
sion and 8 (40%) had undergone polypectomy with the 
Caldwell-luc  procedure. All  50  patients  with  bilateral 
ethmoidal polyps underwent polypectomy/FESS followed 
by steroid therapy. only one patient developed recurrence 
of bilateral ethmoidal polyp. malignancies were treated 
with radiotherapy.
Discussion
Sinonasal masses had predilection for males, demonstrat-
ing a male to female ratio of 1.5:1. it was higher (male-to-
female ratio of 1.7:1) in the study by Zafar et al. 11 from 
india, while a study from nigeria 12 revealed an opposite 
ratio showing female preponderance (M:F ratio of 1:1.2). 
A British review of nasal polyposis reported a ratio at 2:1 
(M:F) 4. The 2nd to 4th decades of life are the most vulner-
able period for development of sinonasal masses. Bakari 
et al. 12 had reported a peak incidence of 33 years, while 
for Zafar et al. 11 the mean age of presentation was 22.5 
years. malignancies have been reported generally after 
the fourth decade of life.
nasal polyps result from chronic inflammation of the 
nasal and sinus mucous membranes and are the most 
common tumours of the nasal cavity. Their exact patho-
genesis is not known, however a strong association with 
allergy,  infection,  asthma  and  aspirin  sensitivity  has 
been implicated 4 13. we found 71.4% of the sinonasal 
masses  to  be  non-neoplastic.  Such  a  high  proportion 
of  non-neoplastic  lesions  has  been  reported  in  previ-
ous studies 11 12 14. nasal polyp was the most common 
non-neoplastic mass and was similarly documented by 
those authors. True nasal polyps are subdivided into al-
lergic  nasal  polyps,  showing  abundant  eosinophils  in 
the stroma in addition to inflammatory cells, whereas in 
the other type viz. inflammatory nasal polyps, there is a 
paucity of eosinophils. Ethmoidal and antrochoanal pol-
yps are generally allergic and inflammatory in nature, 
respectively. This trend was also seen considering the 
two forms of the polyps in the present study. The in-
cidence of rhinoscleroma (10%) was much higher than 
reported by another similar study 11, while no case was 
reported by nigerian 12 or nepali 15 authors. rhinosporo-
diosis, an endemic disease in india, Sri lanka and a few 
African nations 16 was also diagnosed and treated. we 
found 2 cases of rhinosporiodosis, while Pradhananga 
et al. 15 had encountered only one case during their two-
year study period. rhinoscleroma and rhinosporodiosis 
are rare entities in the west (Europe and America) and 
scarcely documented among those who have never trav-
elled to endemic areas 17 18.
haemangioma  is  not  regularly  seen  in  the  nasal  cav-
ity, though if it occurs, is predominantly capillary and is 
found attached to the nasal septum 19. Cavernous haeman-
gioma is rarely seen in the sinonasal tract 20. Among the 
benign lesions, capillary haemangioma (47.3%) was most 
common lesion in our study. All cases were found to be 
arising from the cartilaginous part of the nasal septum. 
This finding corresponds to the observation of Pradhanan-
ga et al. 15. A clinicopathological study of haemangioma 
from Japan reported an usual origin of capillary type from 
the nasal septum and of the cavernous variety from the lat-
eral nasal wall 21. inverted papillomas are comparatively 
rare, but this morphological variant is the most common-
ly encountered lesion of all sinonasal papillomas 22. The 
other two morphological forms are exophytic (everted) 
squamous cell papilloma and cylindric cell papilloma. in-
verted papilloma formed 36.8% of all benign neoplastic 
masses, which was marginally higher from the findings 
of humayun et al. 1 and Bakari et al. 12. Though it is a 
benign lesion but clinically it behaves as a potentially no-
torious pathology if not treated adequately and followed 
adequately.  The  rate  of  malignant  transformation  may 
be as high as 11% 23. inverted papilloma was associated 
with squamous cell carcinoma of the sinonasal cavity in 
6 (21.4%) of the 28 cases studied by Califano et al. in 
uSA 24. mucocele and angifibroma were evident in 2 and 
1 patients, respectively, while Pradhananga et al. 15 report-
ed 9 cases of angiofibroma over a period of two years in 
nepal. Juvenile angiofibroma forms 0.5% of all head and 
neck tumours in Europe 25.
malignancy of sinonasal tract is rare 26. The maxillary si-
nus is the most common site of origin 27, while the most 
common histological type is squamous cell carcinoma 28. 
it is rarely encountered before the 4th decade of life. it 
formed  11.6%  of  all  lesions  and  40.6%  of  neoplastic 
masses in our study. histological investigation revealed 
squamous cell carcinoma in 92.3% (n = 12) of all ma-
lignant neoplastic sinonasal masses, and only 1 slide was 
identified to be adenocarcinoma. Svane-Knudsen et al. 
have similarly reported squamous cell carcinoma to be 
the most commonly encountered malignancy of sinonasal 
tract in Denmark 29. Pradhananga et al. 15 reported 6.3% of 
their sinonasal masses to be malignant, while for Fasunla 
et al. 27 malignant sinonasal tumours constituted 59.4% of 
the 138 sinonasal neoplasms seen. The highest numbers 
of cases were seen in the age group 61-70 years with 7 
study subjects. a Polish study reported 71-80 years to be 
the most commonly affected age group for malignancies 
of the sinonasal tract 30. All the tumours originated in the 
maxillary sinus (100%), eroding the lateral wall of nasal 
cavity.
The common presentation of the sinonasal masses were 
nasal  obstruction,  (97.3%  cases),  rhinorrhoea  (49.1%), 
hyposmia (31.3%) and headache (16.9%). These findings 
compare favourably with other studies 1 12 14 15. intermittent A. lathi et al.
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epistaxis was noticed in 17.9% of cases with 12 of the 
malignant masses showing it as a regular feature. External 
deformity of nose and cheek is more common in neoplas-
tic polypoid lesions, but can also be seen in long standing 
non-neoplastic polyps developing at an early age. unilat-
eral presentation was seen in 48.2% of cases. This was in 
contrast with the observations of Bakari et al. 12 where bi-
lateral sinonasal masses were seen in 44.7% of cases, and 
unilateral  lesions  in  55.3%  of  patients.  non-neoplastic 
inflammatory polyps were usually unilateral and single, 
while allergic polyps were usually bilateral and multiple 
in agreement with the analysis of Frosini et al. 31.
histopathological examination is conclusive in diagnos-
ing the polypoid lesions, describing both aetiology and 
cellular details. it is the only means of determining the 
nature  of  the  disease,  i.e.  inflammatory  or  neoplastic. 
radiological investigations may also help in understand-
ing the type of pathology, extension of lesion and associ-
ated sinus pathology. most of non-neoplastic and benign 
neoplastic nasal masses require surgical excision, while 
malignant neoplastic nasal masses require wide surgical 
excision, radiotherapy or chemotherapy either alone or 
in combination. regular follow-up is necessary for early 
detection of recurrence or metastases. The outcome for 
malignant lesions is relatively poor and associated with 
late diagnosis, difficult surgical anatomy and a lack of ef-
fective adjuvant modalities of treatment 32. Topically ap-
plied corticosteroids have a favourable effect on symp-
toms  33.  however,  corticosteroids  are  only  helpful  in 
allergic conditions. FESS was the most commonly used 
surgical intervention (44.6%) followed by excision of the 
mass (25.0%). Polypectomy and caldwell-luc procedure 
for nasal polyposis are certainly associated with a risk of 
recurrence. FESS offers a definite advantage over other 
procedures and is now the preferred modality 34. Complete 
surgical resection followed by adjuvant radiotherapy is an 
effective and safe approach in the treatment of sinonasal 
cancer and associated with better survival 35 36. however, 
radiotherapy was the only mode of treatment offered to 
patients in our clinic.
Conclusions
Sinonasal  masses  have  various  differential  diagnoses. 
malignancy should be distinguished from non-malignant 
lesions. Benign conditions show a peak during second to 
fourth decade of life, while malignancy is generally ob-
served only after the 4th decade. Polyps are the most com-
mon benign lesion, while squamous cell carcinoma is the 
most common malignant tumour of the sinonasal tract. 
nasal obstruction is the most common symptom. medi-
cal management is often not adequate and has a limited 
role. Surgery is the treatment of choice for benign lesions, 
while a combination of surgery and radiotherapy is help-
ful in malignant conditions. 
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